Liu‐Meng Yang

3.2k total citations
120 papers, 2.6k citations indexed

About

Liu‐Meng Yang is a scholar working on Molecular Biology, Infectious Diseases and Virology. According to data from OpenAlex, Liu‐Meng Yang has authored 120 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Molecular Biology, 46 papers in Infectious Diseases and 38 papers in Virology. Recurrent topics in Liu‐Meng Yang's work include HIV/AIDS drug development and treatment (43 papers), HIV Research and Treatment (38 papers) and Plant-derived Lignans Synthesis and Bioactivity (29 papers). Liu‐Meng Yang is often cited by papers focused on HIV/AIDS drug development and treatment (43 papers), HIV Research and Treatment (38 papers) and Plant-derived Lignans Synthesis and Bioactivity (29 papers). Liu‐Meng Yang collaborates with scholars based in China, Hong Kong and United States. Liu‐Meng Yang's co-authors include Yong‐Tang Zheng, Han‐Dong Sun, Ruirui Wang, Wei‐Lie Xiao, Jian‐Xin Pu, Rong‐Hua Luo, Sheng‐Xiong Huang, Ji‐Kai Liu, Ze‐Jun Dong and Yunhua Wang and has published in prestigious journals such as Nature Communications, PLoS ONE and Chemical Communications.

In The Last Decade

Liu‐Meng Yang

119 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liu‐Meng Yang China 31 1.5k 743 624 446 326 120 2.6k
L. Mark Cosentino United States 23 1.8k 1.2× 876 1.2× 563 0.9× 328 0.7× 250 0.8× 30 3.0k
Keduo Qian United States 32 1.6k 1.0× 895 1.2× 310 0.5× 349 0.8× 293 0.9× 74 2.7k
Chin‐Ho Chen United States 37 2.2k 1.4× 769 1.0× 390 0.6× 855 1.9× 823 2.5× 110 3.6k
Li Huang United States 34 1.3k 0.9× 808 1.1× 224 0.4× 569 1.3× 522 1.6× 100 2.8k
Naheed Mahmood United Kingdom 22 975 0.6× 492 0.7× 493 0.8× 398 0.9× 254 0.8× 62 2.1k
Fidele Ntie‐Kang Cameroon 30 1.2k 0.8× 576 0.8× 690 1.1× 207 0.5× 58 0.2× 114 2.9k
Ghee Teng Tan United States 30 1.1k 0.8× 439 0.6× 650 1.0× 103 0.2× 63 0.2× 56 2.2k
Michael T. Flavin United States 21 795 0.5× 995 1.3× 317 0.5× 294 0.7× 114 0.3× 48 2.1k
Simona Distinto Italy 30 1.5k 1.0× 1.1k 1.5× 135 0.2× 440 1.0× 221 0.7× 83 2.7k
Shiow‐Ju Lee Taiwan 29 977 0.6× 497 0.7× 466 0.7× 314 0.7× 35 0.1× 59 2.3k

Countries citing papers authored by Liu‐Meng Yang

Since Specialization
Citations

This map shows the geographic impact of Liu‐Meng Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liu‐Meng Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liu‐Meng Yang more than expected).

Fields of papers citing papers by Liu‐Meng Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liu‐Meng Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liu‐Meng Yang. The network helps show where Liu‐Meng Yang may publish in the future.

Co-authorship network of co-authors of Liu‐Meng Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Liu‐Meng Yang. A scholar is included among the top collaborators of Liu‐Meng Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liu‐Meng Yang. Liu‐Meng Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luo, Dan, Rong‐Hua Luo, Weilin Wang, et al.. (2024). Discovery of L15 as a novel Vif PROTAC degrader with antiviral activity against HIV-1. Bioorganic & Medicinal Chemistry Letters. 111. 129880–129880. 9 indexed citations
2.
Huang, Xusheng, Yadong Cui, Liu‐Meng Yang, et al.. (2024). Seco-cyclic phorbol derivatives and their anti-HIV-1 activities. Chinese Journal of Natural Medicines. 22(4). 365–374. 1 indexed citations
3.
Zhou, Guangfeng, Feng Li, Chang‐Bo Zheng, et al.. (2023). Antiviral effects of the fused tricyclic derivatives of indoline and imidazolidinone on ZIKV infection and RdRp activities of ZIKV and DENV. Virus Research. 326. 199062–199062. 8 indexed citations
4.
Huang, Xusheng, Hao Sun, Wei Hu, et al.. (2023). Novel Triazolopyridine-Based BRD4 Inhibitors as Potent HIV-1 Latency Reversing Agents. ACS Medicinal Chemistry Letters. 15(1). 60–68. 1 indexed citations
5.
Zhou, Guangfeng, Xintong Ge, Chang‐Bo Zheng, et al.. (2022). Discovery of dehydroandrographolide derivatives with C19 hindered ether as potent anti-ZIKV agents with inhibitory activities to MTase of ZIKV NS5. European Journal of Medicinal Chemistry. 243. 114710–114710. 10 indexed citations
6.
Xie, Xiong, Huan Chen, Jian Li, et al.. (2022). Structure-Based Design of Tropane Derivatives as a Novel Series of CCR5 Antagonists with Broad-Spectrum Anti-HIV-1 Activities and Improved Oral Bioavailability. Journal of Medicinal Chemistry. 65(24). 16526–16540. 5 indexed citations
7.
Zhou, Guangfeng, Jingbo Wang, Chang‐Bo Zheng, et al.. (2022). Identification of 6ω-cyclohexyl-2-(phenylamino carbonylmethylthio)pyrimidin-4(3H)-ones targeting the ZIKV NS5 RNA dependent RNA polymerase. Frontiers in Chemistry. 10. 1010547–1010547. 5 indexed citations
8.
Li, Yiming, Rong‐Hua Luo, Liu‐Meng Yang, et al.. (2020). Design, synthesis and anti-HIV evaluation of 5-alkyl- 6-(benzo[d][1,3]dioxol-5-alkyl)-2-mercaptopyrimidin-4(3H)-ones as potent HIV-1 NNRTIs. Bioorganic Chemistry. 102. 104041–104041. 9 indexed citations
9.
Pang, Weijun, et al.. (2020). Zika virus transmission via breast milk in suckling mice. Clinical Microbiology and Infection. 27(3). 469.e1–469.e7. 8 indexed citations
10.
Yang, Liu‐Meng, Wei Ding, Jiangyuan Wang, et al.. (2019). Synthesis and biological evaluation of a series of 2-(((5-akly/aryl-1H-pyrazol-3-yl)methyl)thio)-5-alkyl-6-(cyclohexylmethyl)-pyrimidin-4(3H)-ones as potential HIV-1 inhibitors. Acta Pharmaceutica Sinica B. 10(3). 512–528. 33 indexed citations
11.
Liu, Yanping, et al.. (2018). A New Stemodane Diterpenoid from the Stems and Leaves of Trigonostemon heterophyllus. Chinese Journal of Organic Chemistry. 38(11). 3137–3137. 2 indexed citations
12.
Zhang, Xing‐Jie, Ruirui Wang, Huan Chen, et al.. (2018). SJP-L-5 inhibits HIV-1 polypurine tract primed plus-strand DNA elongation, indicating viral DNA synthesis initiation at multiple sites under drug pressure. Scientific Reports. 8(1). 5 indexed citations
13.
Liu, Siling, Zhengbo Wang, Dong Chen, et al.. (2017). Annotation and cluster analysis of spatiotemporal- and sex-related lncRNA expression in rhesus macaque brain. Genome Research. 27(9). 1608–1620. 81 indexed citations
14.
Zhang, Xuan, Liu‐Meng Yang, Guang‐Ming Liu, et al.. (2012). Potent Anti-HIV Activities and Mechanisms of Action of a Pine Cone Extract from Pinus yunnanensis. Molecules. 17(6). 6916–6929. 18 indexed citations
15.
Ma, Xiaodong, Qiuqin He, Xuan Zhang, et al.. (2012). Synthesis, structure–activity relationships, and docking studies of N-phenylarylformamide derivatives (PAFAs) as non-nucleoside HIV reverse transcriptase inhibitors. European Journal of Medicinal Chemistry. 58. 504–512. 3 indexed citations
16.
Li, Xiao‐Nian, Chun Lei, Liu‐Meng Yang, et al.. (2011). Three new arylnaphthalene lignans from Schisandra propinqua var. sinensis. Fitoterapia. 83(1). 249–252. 10 indexed citations
17.
Xiao, Wei‐Lie, Ruirui Wang, Wei Zhao, et al.. (2010). Anti-HIV-1 activity of lignans from the fruits of Schisandra rubriflora. Archives of Pharmacal Research. 33(5). 697–701. 19 indexed citations
18.
Lin, Hongwei, Mingxue Sun, Yunhua Wang, et al.. (2010). Anti-HIV Activities of the Compounds Isolated fromPolygonum cuspidatumandPolygonum multiflorum. Planta Medica. 76(9). 889–892. 49 indexed citations
19.
Wang, Ruirui, Qiong Gu, Yunhua Wang, et al.. (2008). Anti-HIV-1 activities of compounds isolated from the medicinal plant Rhus chinensis. Journal of Ethnopharmacology. 117(2). 249–256. 84 indexed citations
20.
Pang, Wei, Ruirui Wang, Liu‐Meng Yang, et al.. (2008). Recombinant protein of heptad-repeat HR212, a stable fusion inhibitor with potent anti-HIV action in vitro. Virology. 377(1). 80–87. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by L. Mark Cosentino Breakdown of academic impact, for papers by Keduo Qian Breakdown of academic impact, for papers by Chin‐Ho Chen Breakdown of academic impact, for papers by Li Huang Breakdown of academic impact, for papers by Naheed Mahmood Breakdown of academic impact, for papers by Fidele Ntie‐Kang Breakdown of academic impact, for papers by Ghee Teng Tan Breakdown of academic impact, for papers by Michael T. Flavin Breakdown of academic impact, for papers by Simona Distinto Breakdown of academic impact, for papers by Shiow‐Ju Lee
Rankless by CCL
2026